C83.08
Small cell B-cell lymphoma, lymph nodes of multiple sites
Clinical Classification Guidelines
Medical Intelligence & Overview
Small cell B-cell lymphoma involving multiple lymph node sites is a type of blood cancer that begins in your lymphatic system. This form of lymphoma is characterized by the growth of abnormal B-cells, which are a type of white blood cell that plays an essential role in your immune response. When these cells become cancerous, they can multiply rapidly and spread to various lymph nodes throughout your body. Recognizing the nature of this disease is crucial for understanding its diagnosis, potential symptoms, and treatment options.
Causes & Symptoms
Clinical Causes: Genetic mutations within B-cells that lead to uncontrolled growth Changes or damage to the immune system, possibly due to infections or immune deficiencies Environmental factors, such as exposure to certain chemicals or radiation, although these are less clearly defined A family history of lymphomas or other hematologic cancers, suggesting a genetic component
Key Symptoms: Swelling or painless lumps in the lymph nodes, commonly found in the neck, armpits, or groin Unexplained weight loss Persistent fever without an infection Night sweats Fatigue or weakness Itching or skin rash in some cases Weight loss and loss of appetite Recurrent infections, due to compromised immune function
Diagnostic & Treatment
Diagnosis Path: Physical examination to identify swollen lymph nodes or other abnormalities Blood tests to evaluate blood cell counts and look for markers of lymphoma Imaging tests such as CT scans, PET scans, or MRI to visualize the affected areas Lymph node biopsy, where a tissue sample is taken for microscopic examination to identify malignant cells Bone marrow biopsy may be performed to determine if the disease has spread to the bone marrow Additional tests like molecular studies can help determine specific genetic features of the cancer
Treatment Protocols: Chemotherapy, often involving combination regimens aimed at destroying cancerous B-cells Immunotherapy, which uses medications to help your immune system recognize and attack cancer cells Targeted therapy that focuses on specific genetic or molecular targets associated with the lymphoma Radiation therapy in some cases, especially when localized to specific lymph nodes or areas Stem cell transplant, which may be considered if the disease is aggressive or relapses after initial treatment
Clinical Advice & FAQs
Billing Guidance
Is C83.08 a billable ICD-10 code?
Yes, C83.08 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C83.08?
Clinical documentation must specify the nature of Small cell B-cell lymphoma, lymph nodes of multiple sites and any associated comorbidities for accurate reporting.
Cite this Clinical Reference